Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Pacific Herald.
Press releases published on April 25, 2025
Oxygen Scavengers Market Size to Progress USD 4.20 Bn by 2034
GlobeNewswire
·
April 25, 2025
Ottawa, April 25, 2025 (GLOBE NEWSWIRE) -- The global oxygen scavengers market size to record USD 2.72 billion in 2025 and is projected to grow beyond USD 4.20 billion by 2034, a study published by Towards Packaging a sister firm of Precedence Research. …
Sagtec Global to Announce Fiscal Year 2024 Financial Results on April 30, 2025
GlobeNewswire
·
April 25, 2025
KUALA LUMPUR, Malaysia, April 25, 2025 (GLOBE NEWSWIRE) -- Sagtec Global Limited (NASDAQ: SAGT) (“Sagtec” or the “Company”), today announced that it will release its financial results for fiscal year 2024, ended December 31, 2024, before markets open on …
BloFin Launches Mastercard Crypto Card Enabling Secure and Effortless Payments
GlobeNewswire
·
April 25, 2025
DUBAI, United Arab Emirates, April 25, 2025 (GLOBE NEWSWIRE) -- BloFin, a global leading cryptocurrency exchange, is proud to announce the official launch of the BloFin Card. The BloFin Card, now available as a virtual offering, enables select users to …
XRP News: Investors Rush Into XenDex Presale As Momentum Builds Across the Ripple Ecosystem
GlobeNewswire
·
April 25, 2025
SYDNEY, April 25, 2025 (GLOBE NEWSWIRE) -- The XRP Ledger is heating up, and XenDex is at the center of the storm. As one of the most advanced decentralized finance platforms to launch on XRPL, XenDex is capturing major attention from both retail investors …
Valve Actuator Market Size is Anticipated to Grow at a CAGR of 5.3%, Reaching USD 24.62 billion by 2031 | The Insight Partners
GlobeNewswire
·
April 25, 2025
US …
Pharming Group announces upcoming presentations at the 2025 Annual Meeting of the Clinical Immunology Society (CIS)
GlobeNewswire
·
April 25, 2025
Leiden, the Netherlands, April 25, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces the following presentations by the Company or its collaborators at the 2025 Annual Meeting of the Clinical …
ALX Oncology Reports ASPEN-03 and ASPEN-04 Phase 2 Trials Evaluating Evorpacept with a Checkpoint Inhibitor for the Treatment of Head and Neck Cancers Did Not Meet Primary Endpoints
GlobeNewswire
·
April 25, 2025
In ASPEN-03 and ASPEN-04 trials, efficacy data do not support advancing evorpacept in combination with Merck’s anti-PD-1 therapy, KEYTRUDA® (pembrolizumab), into a registrational study Company remains confident in continuing to pursue evorpacept in …
Surety Market Size is Anticipated to Grow at a CAGR of 6.6%, Reaching USD 31.85 billion by 2031 | The Insight Partners
GlobeNewswire
·
April 25, 2025
US …
Assisted Reproductive Technology Market worth US$6.02 Billion by 2030 with 7.0% CAGR | MarketsandMarkets™.
GlobeNewswire
·
April 25, 2025
Delray Beach, FL, April 25, 2025 (GLOBE NEWSWIRE) -- The global Assisted Reproductive Technology Market, valued at US$4.02 billion in 2024, is forecasted to grow at a robust CAGR of 7.0%, reaching US$4.29 billion in 2025 and an impressive US$6.02 billion …
Cogent Biosciences Presents Four Posters at the American Association for Cancer Research Annual Meeting 2025 and Announces Two New Leaders
GlobeNewswire
·
April 25, 2025
WALTHAM, Mass. and BOULDER, Colo., April 25, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced preclinical data from four …
Dr. Mohana Rao Patibandla Honored as India’s Best Minimally Invasive Neurosurgeon at Sardar Patel Unity Awards 2025
EIN Presswire
·
April 25, 2025
Dr. Mohana Rao Patibandla Honored as India’s Best Minimally Invasive Neurosurgeon at Sardar Patel Unity Summit …
Eco-Friendly Plasticizers Market worth $7.55 billion by 2030, at 7.0%, says MarketsandMarkets™
GlobeNewswire
·
April 25, 2025
Delray Beach, FL, April 25, 2025 (GLOBE NEWSWIRE) -- In terms of value, the Eco-Friendly Plasticizers Market is projected to reach USD 7.55 billion by 2030 from USD 5.03 billion in 2024, at a CAGR of 7.0%, as per the recent study by MarketsandMarkets™. …
Guardforce AI to Host Year-End 2024 Financial Results Conference Call on Monday, April 28th at 8:30 A.M. ET
GlobeNewswire
·
April 25, 2025
NEW YORK, NY, April 25, 2025 (GLOBE NEWSWIRE) -- Guardforce AI Co., Limited (“Guardforce AI” or the “Company”) (NASDAQ: GFAI, GFAIW), a global integrated security provider specializing in secured logistics, Artificial Intelligence (AI), and Robot-as-a- …
Silicon Motion Confirms Quarterly Dividend
GlobeNewswire
·
April 25, 2025
TAIPEI, Taiwan and MILPITAS, Calif., April 25, 2025 (GLOBE NEWSWIRE) -- Silicon Motion Technology Corporation (NasdaqGS: SIMO)(“Silicon Motion” or the “Company”), a global leader in designing and marketing NAND flash controllers for solid state storage …
Genius Group to Release Full Year 2024 Results and Host Investor Webcast on April 30, 2025
GlobeNewswire
·
April 25, 2025
SINGAPORE, April 25, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, will announce full year 2024 financial results on Wednesday, April 30, 2025, …
Brain Computer Interface Market Size Worth USD 12.40 Bn by 2034, Expands Rapidly as Healthcare and Gaming Sectors Embrace Neurotechnology
GlobeNewswire
·
April 25, 2025
Ottawa, April 25, 2025 (GLOBE NEWSWIRE) -- The brain computer interface market is expected to expand at a double-digit CAGR of 17.35% from 2025 to 2034. The market projected the valuation at USD 2.62 billion in 2024 and is likely to be valued at USD 12.40 …
Clearmind Medicine Files International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders
GlobeNewswire
·
April 25, 2025
Vancouver, Canada, April 25, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …
Junshi Biosciences Announces the sNDA Approval of Toripalimab for the 1st-line Treatment of Melanoma
GlobeNewswire
·
April 25, 2025
SHANGHAI, April 25, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel …
Y-mAbs Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating CD38-SADA Pre-targeted Radioimmunotherapy in Relapsed/Refractory Non-Hodgkin Lymphoma
GlobeNewswire
·
April 25, 2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and antibody-based …
PONY AI Inc. and Tencent Cloud Announce Strategic Partnership to Advance Autonomous Driving Technology and Robotaxi Commercial Deployment
GlobeNewswire
·
April 25, 2025
SHANGHAI, China, April 25, 2025 (GLOBE NEWSWIRE) -- Pony AI Inc. (“Pony.ai” or the “Company”) (Nasdaq: PONY), a global leader in achieving large-scale commercialization of autonomous mobility, announced a strategic partnership with Tencent Cloud and Smart …